Drugs / LV
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01889680 Background | Nov 2014 → May 2016 | colorectal cancer | NSABP Foundation Inc | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01889680 ↗ |
| Route | Intravenous | “400 mg/m2 IV day 1 every 14 days until disease progression” NCT01889680 ↗ |